Market closedNon-fractional
Sanofi/SAN
07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1YMAX
About Sanofi
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, over-the-counter treatments and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 20% of total sales, but profits are shared with Regeneron. About 40% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Ticker
SAN
Sector
Healthcare
Trading on
PAR
Industry
Pharmaceuticals
Headquarters
Paris, France
Employees
86,088
Website
www.sanofi.com
Sanofi Metrics
BasicAdvanced
€122B
Market cap
29.00
P/E ratio
€3.36
EPS
-
Beta
€3.76
Dividend rate
3.86%
Dividend yield
Price and volume
Market cap
€122B
Dividend rate
€3.76
Financial strength
Current ratio
1.002
Quick ratio
0.52
Long term debt to equity
19.502
Total debt to equity
32.537
Dividend payout ratio (TTM)
111.57%
Interest coverage (TTM)
11.25%
Management effectiveness
Return on assets (TTM)
4.10%
Return on equity (TTM)
5.81%
Valuation
Price to earnings (TTM)
29.003
Price to revenue (TTM)
2.597
Price to book
1.68
Price to tangible book (TTM)
-30.14
Price to free cash flow (TTM)
29.484
Dividend yield (TTM)
3.86%
Growth
Revenue change (TTM)
2.04%
Earnings per share change (TTM)
-50.93%
3-year revenue growth (CAGR)
7.76%
3-year earnings per share growth (CAGR)
-9.85%
3-year dividend per share growth (CAGR)
5.52%
What the Analysts think about Sanofi
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Sanofi stock.
Sanofi Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Sanofi Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Sanofi News
AllArticlesVideos
Latest price is delayed by 15 minutes. Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by ICE Data Services and Euronext
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Sanofi stock?
Sanofi (SAN) has a market cap of €122B as of July 27, 2024.
What is the P/E ratio for Sanofi stock?
The price to earnings (P/E) ratio for Sanofi (SAN) stock is 29 as of July 27, 2024.
Does Sanofi stock pay dividends?
Yes, the Sanofi (SAN) stock pays dividends to shareholders. As of July 27, 2024, the dividend rate is €3.76 and the yield is 3.86%. Sanofi has a payout ratio of 111.57% on a trailing twelve-month basis.
When is the next Sanofi dividend payment date?
The next Sanofi (SAN) dividend payment date is unconfirmed.
What is the beta indicator for Sanofi?
Sanofi (SAN) does not currently have a Beta indicator.
Buy or sell Sanofi stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.